Drugs
Other organo-inorganic compounds: > Other: > Aromatic: > Other: > Drugs
Duty Rate (from China)
Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 2931.90.22.00
Aromatic Arsenic Drug Triphenylarsine Oxide
Triphenylarsine oxide is an aromatic organo-arsenic compound used as an intermediate in pharmaceutical synthesis for anti-cancer drugs. It falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug containing arsenic directly linked to carbon, meeting Chapter 29 requirements for chemically defined compounds.
4-Dimethylaminophenylarsine Drug Intermediate
This aromatic organo-arsenic compound serves as a key intermediate in synthesizing anti-parasitic drugs. Classified under HTS 2931.90.22.00 due to its aromatic structure with arsenic directly bonded to carbon and designated pharmaceutical application.
Phenylphosphine Gold Drug Auranofin Intermediate
Auranofin intermediate featuring aromatic phosphine coordinated with gold, used in rheumatoid arthritis treatment. Falls under HTS 2931.90.22.00 as an aromatic organo-inorganic drug with phosphorus and metal directly linked to aromatic carbon.
Aromatic Silane Platinum Anti-Cancer Drug
Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.
Organotin Aromatic Drug Candidate
Aromatic organotin compound under development for anti-microbial pharmaceutical applications. Classified in HTS 2931.90.22.00 as an aromatic organo-inorganic drug with tin directly bonded to aromatic carbon.
Ferrocene Aromatic Drug Derivative
Ferrocene-based aromatic metallocene used in anti-cancer drug development with iron-carbon sandwich structure. HTS 2931.90.22.00 covers this aromatic organo-inorganic pharmaceutical as metal is linked through carbon atoms.
Aryl Boronic Acid Platinum Drug Complex
Platinum anti-tumor agent featuring aromatic boronic acid ligands for targeted cancer therapy. Falls under HTS 2931.90.22.00 as aromatic organo-inorganic containing boron and platinum linked to carbon.
Phosphorus Aromatic Selenide Drug
Aromatic organo-selenium phosphorus compound for antioxidant pharmaceutical applications. HTS 2931.90.22.00 classification for aromatic drugs containing phosphorus and selenium directly linked to carbon.